Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidate, tovecimig, is a bispecific antibody that targets delta-like ligand 4...
44 insider purchases on record · latest filing 2026-04-30.
Insiders have also filed 16 sale transactions at CMPX.